Search results
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...
WKBN 27 Youngstown· 5 hours agoOf the 37 patients evaluable for efficacy assessment, the objective response rate (ORR) and disease control rate (DCR) were 62.2% and 91.9%, respectively, with median progression-free ...
Is Expired Medication Safe To Use? Pharmacists Reveal When Good Meds Go Bad
Woman's World via Yahoo News· 7 hours ago"Manufacturers must provide evidence of their product’s stability, purity, potency and efficacy...
ASCO: Early peek at Merus' bispecific cancer data lives up to investors' expectations
FierceBiotech· 6 hours agoAnalysts have hailed Merus’ latest data drop in head and neck cancer as meeting investors’...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 6 hours agoThe abstracts were released after market closed on 23 May and shares in Merus rose by 15% in...
Merus Clears Wall Street's Bar With Cancer Data
Barrons.com· 2 hours agoMerus appears to have cleared the bar set by Wall Street for its highly watched cancer-treatment candidate. The company posts an abstract for its head...
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at...
WKBN 27 Youngstown· 1 day agoOn May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal cell carcinoma ...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga· 4 hours agoThursday, Verastem Oncology VSTM announced the initial interim safety and efficacy results from the...
Imaginary placebo intake study investigates neural response for regulating disgust
Medical Xpress· 2 hours agoA study has compared the effects of a placebo pill and an imaginary pill in reducing visually...
Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929...
FOX 5 San Diego· 6 hours agoRakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based on its proprietary Alluminox™ platform, today announced ...
Medtronic's (MDT) OmniaSecure Lead Favored in the LEADR Trial
Zacks via Yahoo Finance· 5 hours agoImage Source: Zacks Investment Research The primary outcome revealed that the defibrillation testing...